Family strategies support ailing child
Jane Brody outlines the toll of chronic illness in a child on families, noting emotional and financial strain, impact on marriages, and effects on healthy siblings. The piece cites a 1985 Vanderbilt study and offers coping steps, including support groups, selfcare, honest explanations, and practical resources from the Association for the Care of Children's Health.
MENTIONED IN THIS ARTICLE
New York
America
Vanderbilt University Medical School
Vanderbilt
Association For the Care of Children’s Health
Wisconsin Ave
N.W
Washington, D.C
Association For
Association
Inventive Minds shaped by a hands on North Dakota warden
Thomas Powers, North Dakota’s warden of the state penitentiary, runs a small facility like a business. He walks the yard, meets 20 to 25 inmates weekly, and emphasizes rehabilitation over punishment. Staff praise his hands on style and rapport with inmates while noting his goal of reduced recidivism and expanded treatment programs.
MENTIONED IN THIS ARTICLE
Bismarck
N.D
Thomas Powers
MBWA
Powers
Robert Cartledge
Laverne
Charley
Fasthorse
Tom
U.S. Justice Department
Tennessee
North Dakota
North Dakota State Penitentiary
Syracuse
N.Y
Pennsylvania
Villanova University
Pennsylvania Department of Corrections Training Academy
Cumberland County
Carlisle
Bradford County
Towanda
Chink in cockroaches armor sparks new insecticide hope
Washington University chemist Jacob Schaefer uses nuclear magnetic resonance imaging to probe the cockroach exoskeleton production. He and Kansas State University chemist Karl J. Kramer aim to identify enzymes to block shell formation, potentially enabling a new, less toxic control method. experts caution the approach may fail and emphasize improving nonchemical pest controls to avoid resistance and environmental harm.
MENTIONED IN THIS ARTICLE
ST. Louis
Jacob Schaefer
Schaefer
Washington University
Karl J. Kramer
Kansas State University
U.S. Department of Agriculture
Agricultural Research Service
Hospitals to test lazaroid drug for head injuries nationwide
A new steroid-like lazanoid drug to treat severe head injuries moves toward emergency room trials. If effective, it could reduce the 60,000 to 80,000 annual deaths and mirrors how clot-busting drugs transformed heart attack care. Early human tests are safe with no major side effects. FDA approval for 100 to 200 patients at five trauma centers is anticipated next year.
MENTIONED IN THIS ARTICLE
Atlanta
Clothis
Upjohn Co
Food and Drug Administration
United States
Also Mentioned on This Page
Jane Brody
New York Times News Service
The
Journal-World
Bob Moen
Associated Press
Bush
ED Schafer
Kramer
Robert L. Metcalf
University of Illinois
World Health Organization
Metcalf
U.S
ONIEN
National Coalition Against Domestic Violence
U.S. News and World Report Magazine
Copley News Service
Ken Marshal